Upstate Active Clinical Trials Seeking Participants
Study title
ROLE of HTLVS and related endogenous sequences in autoimmune diseases and human cancers
IRB number
3805F
What is the purpose of the study?
We are studying the HTLV/human T-cell leukemia virus-related endogenous sequence, HRES-1. The HRES-1 gene may help to regulate the body's autoimmune response. We are studying the role of this gene in patients with autoimmune diseases (such as lupus, multiple sclerosis) and cancer, their family members and in healthy volunteers. Genes are composed of the genetic material called DNA. DNA (deoxyribonucleic acid) is the part of the cell that is responsible for providing hereditary characteristics (such as eye color) and is used to build proteins. Several genes have been discovered that are associated with autoimmune diseases and cancer. We would like to study your (your child's) DNA to determine whether you have (your child has) an abnormality in these genes, or to find new genes that cause these problems. Participation in this study will involve you (your child) to donate blood.
Who is eligible?
Patients and local family members over the age of 18, healthy volunteers over the age of 18, distant family members over the age of 18
What is involved if I participate?
- How long is the study?
30 Minutes - Is transportation provided or reimbursed?
Yes - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
Complete consent form to draw blood and draw blood from the arm
Who is the doctor administering the study?
Andras Perl, M.D., Ph.D.
Where will the study take place?
SUNY Upstate Medical University; 750 East Adams Street; 8301 Weiskotten Hall, Syracuse, NY 13210
Over what time period is the study scheduled to run?
November 4, 2006 - ongoing
Who can I contact for more information?
- Name: Sara Wierzbicki
- Phone: 315-464-2117
- Email: Wierzbis@upstate.edu
- Fax: 315-464-1947
If you are interested in this trial, please contact the study coordinator or investigator noted above.
